Utama › Dermatitis Atopik (Eksim)
Kajian klinikal Dermatitis Atopik (Eksim) sedang mengambil peserta di AS
62 kajian untuk Dermatitis Atopik (Eksim) sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY13 kajian
- Washington, DC11 kajian
- Los Angeles, CA11 kajian
- San Diego, CA10 kajian
- San Antonio, TX10 kajian
- Miami, FL9 kajian
- Birmingham, AL9 kajian
- Troy, MI8 kajian
- Huntington Beach, CA8 kajian
- Dallas, TX8 kajian
- Sacramento, CA8 kajian
- Tampa, FL7 kajian
- Indianapolis, IN7 kajian
- Pittsburgh, PA7 kajian
- Philadelphia, PA6 kajian
- Santa Monica, CA6 kajian
- Chicago, IL6 kajian
- Phoenix, AZ6 kajian
- Sugar Land, TX6 kajian
- Santa Clarita, CA6 kajian
- Las Vegas, NV5 kajian
- St. Petersburg, FL5 kajian
- Charleston, SC5 kajian
- Portland, OR5 kajian
- Little Rock, AR5 kajian
- Louisville, KY4 kajian
- Cleveland, OH4 kajian
- Arlington, TX4 kajian
- Fremont, CA4 kajian
- Harrisburg, PA4 kajian
- Portsmouth, NH4 kajian
- Miami Gardens, FL4 kajian
- Newton, MA4 kajian
- Morgantown, WV4 kajian
- San Francisco, CA4 kajian
- Fargo, ND4 kajian
- Coral Springs, FL4 kajian
- Baltimore, MD4 kajian
- Ann Arbor, MI4 kajian
- Norfolk, VA3 kajian
Mengikut negeri
- Alabama9 kajian
- Arizona7 kajian
- Arkansas8 kajian
- California30 kajian
- Colorado4 kajian
- Florida18 kajian
- Georgia9 kajian
- Idaho4 kajian
- Illinois10 kajian
- Indiana9 kajian
- Kentucky4 kajian
- Maryland16 kajian
- Massachusetts6 kajian
- Michigan14 kajian
- Missouri7 kajian
- Nebraska4 kajian
- Nevada6 kajian
- New Hampshire5 kajian
- New Jersey3 kajian
- New York16 kajian
- North Carolina8 kajian
- North Dakota4 kajian
- Ohio10 kajian
- Oregon6 kajian
- Pennsylvania13 kajian
- South Carolina10 kajian
- Texas18 kajian
- Utah4 kajian
- Virginia5 kajian
- Washington3 kajian
- West Virginia4 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Natural History and Genetics of Food Allergy and Related Conditions
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
1 Day – 99 Years · Semua jantina · Dikemas kini 2 Okt 2026 · NCT02504853Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
Mengambil pesertaFasa 1
Umur 12 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07262983Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07453602A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 72 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06808477This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Mengambil pesertaFasa 2
Umur 18 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06947993Effects of Treatments on Atopic Dermatitis
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
Umur 2 hingga 50 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT01631617Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07298395First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07527923A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Mengambil pesertaFasa 3
Umur 2 hingga 11 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06807281A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Mengambil pesertaFasa 2
Umur 18 hingga 64 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07003425Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04864886Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 2 hingga 100 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT00605878Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Mengambil pesertaKajian pemerhatian
Umur 12 hingga 89 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07645820The Impact of Dietary Salt on the Severity of Eczema
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07447063The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07487831Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Mengambil peserta
Umur 13 hingga 17 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07746427A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
Mengambil pesertaFasa 2/3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07355075A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07223697A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07599813CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT04504955Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
Mengambil pesertaFasa 2
Umur 3 hingga 21 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT03835767Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06899204Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.